Which trial do we need? Empiric Glycopeptides plus clindamycin versus Oxazolidinones for suspected toxic shock and necrotizing soft tissue infections.
Osowicki, J; Hamilton, F; Lee, TC; Marks, M
; McCreary, EK; McDonald, EG; Ryder, JH; Tong, SY and
(2024)
Which trial do we need? Empiric Glycopeptides plus clindamycin versus Oxazolidinones for suspected toxic shock and necrotizing soft tissue infections.
Clinical microbiology and infection, 30 (5).
pp. 570-573.
ISSN 1198-743X
DOI: 10.1016/j.cmi.2024.02.001
; McCreary, EK; McDonald, EG; Ryder, JH; Tong, SY and
(2024)
Which trial do we need? Empiric Glycopeptides plus clindamycin versus Oxazolidinones for suspected toxic shock and necrotizing soft tissue infections.
Clinical microbiology and infection, 30 (5).
pp. 570-573.
ISSN 1198-743X
DOI: 10.1016/j.cmi.2024.02.001
-
picture_as_pdf - Osowicki-etal-2024-Which-trial-do-we-need.pdf
-
subject - Accepted Version
-
error - This is an author accepted manuscript version of an article accepted for publication, and following peer review. Please be aware that minor differences may exist between this version and the final version if you wish to cite from it.
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 4.0
Downloads